- No inpatient stay!
- 12 day-time outpatient appointments & 6 follow-up phone calls
- 12 month study duration
Participants will be reimbursed $3,260 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
This study is testing a new vaccine for the prevention of malaria.
Malaria is a leading cause of disease and mortality in much of the developing world. An estimated 219 million cases and 435,000 deaths occurring in 2017 (WHO Malaria Report 2018), most deaths occurred in African children younger than 5 years old.
There is currently no approved vaccine for Malaria but you can help with this important research.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Outpatient Only Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!